CV Sciences, Inc. (CVSI) Financial Statements (2025 and earlier)

Company Profile

Business Address 9530 PADGETT STREET
SAN DIEGO, CA 92126
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4541,3176111,3754,0249,107
Cash and cash equivalent4541,3176111,3754,0249,107
Receivables5224317662,0411,1262,177
Inventory, net of allowances, customer advances and progress billings4,8975,6556,5638,6248,8409,971
Inventory4,8975,6556,5638,6248,8409,971
Prepaid expense   3,1902,1462,37210,611
Other undisclosed current assets370535  501501
Total current assets:6,2437,93811,13014,18616,86332,367
Noncurrent Assets
Operating lease, right-of-use asset94167275 3,0578,709
Property, plant and equipment3993795751,7172,8773,615
Intangible assets, net (including goodwill)1,0644202511,4856,5186,554
Goodwill971342  2,7882,788
Intangible assets, net (excluding goodwill)93782511,4853,7303,766
Other noncurrent assets1272965056781,3101,442
Total noncurrent assets:1,6841,2621,6063,88013,76220,320
TOTAL ASSETS:7,9279,20012,73618,06630,62552,687
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,3495,73111,97413,53911,48212,473
Accounts payable1,9252,3092,2842,6241,6771,617
Accrued liabilities3,4243,4229,69010,9159,80510,856
Debt   3102,174723
Other undisclosed current liabilities7603841,340612680 
Total current liabilities:6,1096,11513,31414,46114,33613,196
Noncurrent Liabilities
Long-term debt and lease obligation    3,4679,517
Long-term debt, excluding current maturities      
Liabilities, other than long-term debt23182199621,610827
Deferred revenue     1,453 
Deferred income tax liabilities4191162157421
Other liabilities  105   406
Operating lease, liability1958188 3,4679,517
Total noncurrent liabilities:23182199625,07710,344
Total liabilities:6,1326,29713,51314,52319,41323,540
Equity
Equity, attributable to parent1,7952,903(777)3,54311,21229,147
Common stock181615111010
Additional paid in capital88,77387,46486,89783,00775,12370,774
Accumulated other comprehensive income (loss)(15)10    
Accumulated deficit(86,981)(84,587)(87,689)(79,475)(63,921)(41,637)
Total equity:1,7952,903(777)3,54311,21229,147
TOTAL LIABILITIES AND EQUITY:7,9279,20012,73618,06630,62552,687

Income Statement (P&L) ($ in thousands)

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues15,70516,00416,20520,04824,42953,696
Cost of revenue(8,537)(8,919)(10,655)(11,432)(13,420)(18,608)
Gross profit:7,1687,0855,5508,61611,00935,088
Operating expenses(9,358)(9,896)(12,397)(27,062)(33,601)(52,328)
Other undisclosed operating income 6,171    
Operating income (loss):(2,190)3,360(6,847)(18,446)(22,592)(17,240)
Nonoperating expense
(Other Nonoperating expense)
(212)(264)    
Interest and debt expense  1272,945  
Income (loss) from continuing operations before equity method investments, income taxes:(2,402)3,096(6,720)(15,501)(22,592)(17,240)
Other undisclosed income (loss) from continuing operations before income taxes   (1,541)(140)(9)15
Income (loss) from continuing operations before income taxes:(2,402)3,096(8,261)(15,641)(22,601)(17,225)
Income tax benefit864787317615
Income (loss) from continuing operations:(2,394)3,102(8,214)(15,554)(22,284)(16,610)
Loss before gain (loss) on sale of properties:(15,554)(22,284)(16,610)
Net income (loss) attributable to parent:(2,394)3,102(8,214)(15,554)(22,284)(16,610)
Other undisclosed net loss available to common stockholders, basic   (920)   
Net income (loss) available to common stockholders, diluted:(2,394)3,102(9,134)(15,554)(22,284)(16,610)

Comprehensive Income ($ in thousands)

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):(2,394)3,102(8,214)(15,554)(22,284)(16,610)
Comprehensive income (loss):(2,394)3,102(8,214)(15,554)(22,284)(16,610)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(25)10    
Comprehensive income (loss), net of tax, attributable to parent:(2,419)3,112(8,214)(15,554)(22,284)(16,610)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: